Patent · US Active

Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use

US8742119B2 · kind B2 · utility

37Cited by

32References

14Claims

0Family size

Assignee

Agios Pharmaceuticals, Inc. · US

Inventors

Francesco G. Salituro · Marlborough, US
Jeffrey O. Saunders · Acton, US

Key dates

Filing date	Oct 6, 2011
Grant date	Jun 3, 2014
Priority date	—
Expiry date	Oct 6, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.